Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.49
-0.33 (-4.84%)
Mar 31, 2025, 1:35 PM EDT - Market open
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $258.28 million as of March 31, 2025. Its market cap has decreased by -23.67% in one year.
Market Cap
258.28M
Enterprise Value
226.40M
1-Year Change
-23.67%
Ranking
Category
Stock Price
$6.49
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $258.28M, a decrease of -80.63%. That is a compound annual growth rate of -30.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 271.41M | 1.23% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |